Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

4562 ARTÍCULOS , VIENDO DEL 1021 AL 1035

Regulation by Nicotinic Acetylcholine Receptors of Microglial Glutamate Transporters: Role of Microglia in Neuroprotection

Morioka N, Hisaoka-Nakashima K, Nakata Y.

2018 Apr 4. In: Akaike A, Shimohama S, Misu Y, editors. Nicotinic Acetylcholine Receptor Signaling in Neuroprotection [Internet]. Singapore: Springer; 2018. Chapter 5.

Roles of Nicotinic Acetylcholine Receptors in the Pathology and Treatment of Alzheimer’s and Parkinson’s Diseases

Shimohama S, Kawamata J.

2018 Apr 4. In: Akaike A, Shimohama S, Misu Y, editors. Nicotinic Acetylcholine Receptor Signaling in Neuroprotection [Internet]. Singapore: Springer; 2018. Chapter 8.

Our Tau Tales from Normal to Pathological Behavior

Alonso AD, Cohen LS.

J Alzheimers Dis. 2018;64(s1):S507-S516. doi: 10.3233/JAD-179906.

Impact of Subthalamic Deep Brain Stimulation Frequency on Upper Limb Motor Function in Parkinson's Disease

Momin S, Mahlknecht P, Georgiev D, Foltynie T, Zrinzo L, Hariz M, Zacharia A, Limousin P.

J Parkinsons Dis. 2018;8(2):267-271. doi: 10.3233/JPD-171150.

Cognitive Rehabilitation in Parkinson's Disease: A Systematic Review

Alzahrani H, Venneri A.

J Parkinsons Dis. 2018;8(2):233-245. doi: 10.3233/JPD-171250.

Targeting AMPK Signaling as a Neuroprotective Strategy in Parkinson's Disease

Curry DW, Stutz B, Andrews ZB, Elsworth JD.

J Parkinsons Dis. 2018;8(2):161-181. doi: 10.3233/JPD-171296.

Role of Plant-Derived Flavonoids and Their Mechanism in Attenuation of Alzheimer's and Parkinson's Diseases: An Update of Recent Data

Hussain G, Zhang L, Rasul A, Anwar H, Sohail MU, Razzaq A, Aziz N, Shabbir A, Ali M, Sun T.

Molecules. 2018 Apr 2;23(4):814. doi: 10.3390/molecules23040814.

Alterations in white matter network topology contribute to freezing of gait in Parkinson's disease

Hall JM, Shine JM, Ehgoetz Martens KA, Gilat M, Broadhouse KM, Szeto JYY, Walton CC, Moustafa AA, Lewis SJG.

J Neurol. 2018 Jun;265(6):1353-1364. doi: 10.1007/s00415-018-8846-3. Epub 2018 Apr 3.

New Imaging Markers for Movement Disorders

Ghadery C, Strafella AP.

Curr Neurol Neurosci Rep. 2018 Apr 3;18(5):22. doi: 10.1007/s11910-018-0830-x.

Mitochondrial Dysfunction in Parkinson's Disease: New Mechanistic Insights and Therapeutic Perspectives

Park JS, Davis RL, Sue CM.

Curr Neurol Neurosci Rep. 2018 Apr 3;18(5):21. doi: 10.1007/s11910-018-0829-3.

Cholinergic forebrain density loss in Parkinson disease: More than just cognitive changes

Bohnen NI, Teipel SJ.

Neurology. 2018 May 1;90(18):823-824. doi: 10.1212/WNL.0000000000005408. Epub 2018 Apr 4.

Baseline symptoms and basal forebrain volume predict future psychosis in early Parkinson disease

Barrett MJ, Blair JC, Sperling SA, Smolkin ME, Druzgal TJ.

Neurology. 2018 May 1;90(18):e1618-e1626. doi: 10.1212/WNL.0000000000005421. Epub 2018 Apr 4.

An Inflammation-Centric View of Neurological Disease: Beyond the Neuron

Skaper SD, Facci L, Zusso M, Giusti P.

Front Cell Neurosci. 2018 Mar 21;12:72. doi: 10.3389/fncel.2018.00072. eCollection 2018.

Quantitative assessment of finger tapping characteristics in mild cognitive impairment, Alzheimer's disease, and Parkinson's disease

Roalf DR, Rupert P, Mechanic-Hamilton D, Brennan L, Duda JE, Weintraub D, Trojanowski JQ, Wolk D, Moberg PJ.

J Neurol. 2018 Jun;265(6):1365-1375. doi: 10.1007/s00415-018-8841-8. Epub 2018 Apr 4.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias